Benefits of Point-of-Care Glucose Testing and Insulin Supplementation at Bedtime in Insulin Treated Patients With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 05 Jan 2018
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Dec 2017 Status changed from recruiting to completed.
- 09 Jul 2013 Planned End Date changed from 1 May 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 24 Oct 2012 New trial record